You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 108 MCY-M11, a CAR-PBMC cell product transiently expressing a mesothelin targeted mRNA CAR, exhibits desirable functional and immune phenotype attributed to sustained antitumor immunity in vitro

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Cellular therapies
108 MCY-M11, a CAR-PBMC cell product transiently expressing a mesothelin targeted mRNA CAR, exhibits desirable functional and immune phenotype attributed to sustained antitumor immunity in vitro

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020235024
Dec 20203406
Jan 20213604
Feb 20212205
Mar 20212706
Apr 202162013
May 20211009
Jun 20210023
Jul 20210015
Aug 2021009
Sep 2021007
Oct 202190040
Nov 202135015
Dec 20212609
Jan 20221602
Feb 20222504
Mar 20223806
Apr 202268015
May 20224004
Jun 20223508
Jul 20224406
Aug 202238010
Sep 20224905
Oct 20225104
Nov 20221604
Dec 20225002
Jan 20233404
Feb 202332010
Mar 20232108
Apr 202344011
May 20233406
Jun 20233209
Jul 202342011
Aug 20234207
Sep 20232608
Oct 202328012
Nov 20236209
Dec 20235403
Jan 2024806
Feb 20244408
Mar 202448016
Apr 202454012
May 20245009
Jun 202462021
Jul 202464011
Aug 202470012
Sep 202454011
Oct 202486035
Nov 202498054
Dec 202464017
Jan 2025138033
Feb 202536013
Mar 20250013
Apr 20250019
May 20250012
Jun 2025006
Total23740661